The unsustainability of clinical trials and need for transformative change
Pharmaceutical Technology
JULY 11, 2025
The rising volume of clinical trials increases demand and competition for patients The number of oncology assets in the clinical development pipeline has increased by 13% annually over five years (2018-2022) 1. On paper, this sounds like a positive time for medical innovation. Sign up for our daily news round-up!
Let's personalize your content